×

What are you searching for?




Healthcare

4 Min read

KYOTO UNIV. RESEARCH ON COVID-19 TREATMENT VIA iPS CELL TECHNOLOGY

Published On 09 Nov 2020 12:13 PM


SHARE THIS ARTICLE  


Highlights –

  • Kyoto Univ. research on COVID-19 treatment via iPS cell technology.
  • Researchers aim to develop COVID-19 treatment by creating cytotoxic T cells in the bloodstream from iPS cells.
  • Cytotoxic T cells play an important role in the immune response of cells.
  • The Japan Agency for Medical Research and Development adopted the program in fiscal 2020.

Tags : JAPAN COVID-19, JAPAN CORONAVIRUS, KYOTO UNIVERSITY, iPS CELL TECHNOLOGY, CYTOTOXIC T CELLS, JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)